A comparison of drug therapy problems in patients eligible and ineligible for provincial medication review programs in Canada

Abstract

Get full access to this article

View all access options for this article.

References

Pammett

Jorgenson

Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott) 2014;147:20-4.

Townsend

Inconsistencies in eligibility criteria for medication assessment programs. Can Pharm J (Ott) 2014;147:136.

Field

Gurwitz

Harrold

. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004;52:1349-54.

Hanlon

Schmader

Koronkowski

. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-8.

Koecheler

Abramowitz

Swim

Daniels

CE.

Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.

Quintana Barcena

Lord

Jouini

. Development of a new tool to evaluate the severity of drug-related problems in chronic kidney disease patients. 2012. Available: http://posterdocuments.com/posters/v/id/480 (accessed June 25, 2013).

Pammett

Blackburn

Taylor

. Evaluation of a community pharmacy–based screening questionnaire to identify patients at risk for drug therapy problems. Pharmacother J Hum Pharmacol Drug Ther 2015;35:881-6.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB